Comparison of Results of Myringoplasty Using Biodesign - an Otologic Graft Made From Porcine Small Intestinal Submucosa, Temporalis Fascia, or Tragal Perichondrium - a Retrospective Cohort Analysis
Biodesign
Comparison of Myringoplasty Using Porcine Small Intestinal Submucosa (Biodesign) Versus Autologous Grafts (Perichondrium, Temporalis Fascia, Cartilage, or Fat) for Tympanic Membrane Perforation Closure: A Retrospective Cohort Study
1 other identifier
observational
60
1 country
1
Brief Summary
The goal of this observational, retrospective study is to learn whether a ready-made graft patch (Biodesign, made from porcine small intestinal submucosa) works as well as a participant's own tissue graft (such as tragal perichondrium or temporalis fascia) to close a hole in the eardrum (tympanic membrane perforation). The main questions this study aims to answer are: Does the eardrum hole close after surgery, and is the closure rate similar between Biodesign and autologous tissue grafts? Do participants have similar hearing improvement after surgery (measured by the air-bone gap, a common hearing test measure)? Is the operating time different between the graft types? Are there differences in complications or adverse reactions? Study hypothesis: Biodesign will have a similar eardrum closure rate compared with autologous tissue grafts, with similar hearing improvement and low complication rates, and may be associated with a shorter operating time. How the study will work: Investigators will review medical records of participants who had myringoplasty/tympanoplasty for eardrum perforation in the department between 2020 and 2024. Data already recorded as part of usual care will be collected, including: pre-surgery eardrum findings (size and location of the perforation) and hearing tests; operative details (technique and operating time); and follow-up at about 3 months, including an ear exam to confirm closure and check for adverse reactions, plus a hearing test. Participants will be excluded if they have other ear conditions (such as cholesteatoma, otosclerosis, or tympanosclerosis), if the eardrum was described as flaccid, or if follow-up or post-operative hearing data are missing.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jan 2020
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2025
CompletedFirst Submitted
Initial submission to the registry
January 1, 2026
CompletedFirst Posted
Study publicly available on registry
July 13, 2026
CompletedJuly 13, 2026
July 1, 2026
5 years
January 1, 2026
July 6, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Tympanic membrane perforation status (closed vs not closed)
Tympanic membrane status will be determined from postoperative ear examination (otoscopy or microscopy) documented in the medical record. The measure is the proportion of participants with an intact tympanic membrane (no residual perforation) at the follow-up visit closest to 3 months after surgery.
Three months after surgery
Secondary Outcomes (1)
Change in air-bone gap (operated ear)
Three months after surgery
Other Outcomes (2)
Operative time
Perioperative (day of surgery)
Adverse events
three months after surgery
Study Arms (2)
Biodesign
Participants with tympanic membrane perforation who underwent myringoplasty/tympanoplasty using a porcine small intestinal submucosa (Biodesign) graft for perforation repair.
Autologous grafts
Participants with tympanic membrane perforation who underwent myringoplasty/tympanoplasty using the participant's own tissue for perforation repair (tragal perichondrium, temporalis fascia, cartilage, or fat), as documented in the operative report.
Interventions
Porcine small intestinal submucosa graft (Biodesign) A commercially available extracellular matrix sheet made from porcine small intestinal submucosa (SIS), supplied as a sterile, freeze-dried soft-tissue graft. The surgeon uses the SIS sheet as the tympanic membrane graft to seal the perforation during myringoplasty.
A graft made from the participant's own tissue harvested at surgery and used to repair the tympanic membrane perforation. In this dataset, autologous grafts are primarily tragal perichondrium and temporalis fascia. This approach requires a donor-site harvest and the graft is shaped and placed to cover the perforation
Eligibility Criteria
Participants were selected from the otology practice of our department and included people diagnosed with a tympanic membrane perforation who underwent myringoplasty/tympanoplasty performed by our surgical team between 2020 and 2024. Cases were be identified from operative records and medical charts, with baseline and follow-up information obtained from routine clinic documentation and audiology testing performed as part of usual care
You may qualify if:
- Patients diagnosed with tympanic membrane perforation and undergoing myringoplasty by our department between 2020 and 2024
You may not qualify if:
- Patients with cholesteatoma, otosclerosis, tympanosclerosis.
- Operations that describe a flaccid tympanic membrane and those that included more than one graft material.
- No follow up data or no post-operative audiometry.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Wolfson Medical Center
Holon, 5822012, Israel
Related Publications (5)
Yawn RJ, Dedmon MM, O'Connell BP, Virgin FW, Rivas A. Tympanic Membrane Perforation Repair Using Porcine Small Intestinal Submucosal Grafting. Otol Neurotol. 2018 Jun;39(5):e332-e335. doi: 10.1097/MAO.0000000000001792.
PMID: 29738388RESULTD'Eredita R. Porcine small intestinal submucosa (SIS) myringoplasty in children: A randomized controlled study. Int J Pediatr Otorhinolaryngol. 2015 Jul;79(7):1085-9. doi: 10.1016/j.ijporl.2015.04.037. Epub 2015 Apr 30.
PMID: 25956867RESULTCho YS, Choi SH, Park KH, Park HJ, Kim JW, Moon IJ, Rhee CS, Kim KS, Sun DI, Lee SH, Koo JW, Koh YW, Lee KH, Lee SW, Oh KW, Pyo EY, Lee A, Kim YT, Lee CH. Prevalence of otolaryngologic diseases in South Korea: data from the Korea national health and nutrition examination survey 2008. Clin Exp Otorhinolaryngol. 2010 Dec;3(4):183-93. doi: 10.3342/ceo.2010.3.4.183. Epub 2010 Dec 22.
PMID: 21217958RESULTKim AS, Betz JF, Reed NS, Ward BK, Nieman CL. Prevalence of Tympanic Membrane Perforations Among Adolescents, Adults, and Older Adults in the United States. Otolaryngol Head Neck Surg. 2022 Aug;167(2):356-358. doi: 10.1177/01945998211062153. Epub 2021 Dec 7.
PMID: 34874794RESULTPannu KK, Chadha S, Kumar D, Preeti. Evaluation of hearing loss in tympanic membrane perforation. Indian J Otolaryngol Head Neck Surg. 2011 Jul;63(3):208-13. doi: 10.1007/s12070-011-0129-6. Epub 2011 Feb 23.
PMID: 22754796RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 1, 2026
First Posted
July 13, 2026
Study Start
January 1, 2020
Primary Completion
January 1, 2025
Study Completion
January 1, 2025
Last Updated
July 13, 2026
Record last verified: 2026-07
Data Sharing
- IPD Sharing
- Will not share